source
- FDA lifts hold on Aardvark Therapeutics' ARD-101 after safety study shows no cardiac eventsFDA has lifted the clinical hold on Aardvark Therapeutics' ARD-101 after the company completed an additional safety study. The new data showed no cardiac events, addressing the concerns that prompt…
- Star Therapeutics raises $200 million to build new drug pipeline after Vega and Electra winsStar Therapeutics announced it has secured $200 million in financing. The capital will be used to develop its own pipeline of medicines, aiming to replicate the success of its earlier Vega and Ele…